BioCentury
ARTICLE | Company News

Management Tracks: BioCryst hires its first CBO; plus ObsEva, Veracyte and more

July 1, 2019 11:56 PM UTC

Rare disease company BioCryst Pharmaceuticals Inc. (NASDAQ:BCRX) hired Megan Sniecinski as its first CBO. She was SVP of business operations and program management at PTC Therapeutics Inc. (NASDAQ:PTCT).

Reproductive health company ObsEva S.A. (NASDAQ:OBSV; SIX:OBSN) hired Elizabeth Garner as CMO. She succeeds CMO Elke Bestel, who will become VP, head of drug safety and pharmacovigilance. Garner was CMO, SVP clinical development at Agile Therapeutics Inc. (NASDAQ:AGRX)...